Treatment patterns, outcomes and health care resource utilization in advanced NSCLC patients without actionable mutations following introduction of immunotherapy: Japan Real-World Evidence in Lung Cancer - Immuno-Oncology
Latest Information Update: 25 Jan 2022
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms JEWEL-IN
- Sponsors MSD KK
- 20 Dec 2021 New trial record